129 related articles for article (PubMed ID: 36332556)
1. Tumour-stroma ratio to predict pathological response to neo-adjuvant treatment in rectal cancer.
Strous MTA; Faes TKE; Heemskerk J; Lohman BGPM; Simons PCG; Janssen Heijnen MLG; Vogelaar FJ; de Bruïne AP
Surg Oncol; 2022 Dec; 45():101862. PubMed ID: 36332556
[TBL] [Abstract][Full Text] [Related]
2. The value of the tumour-stroma ratio for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer: a case control study.
Liang Y; Zhu Y; Lin H; Zhang S; Li S; Huang Y; Liu C; Qu J; Liang C; Zhao K; Li Z; Liu Z
BMC Cancer; 2021 Jun; 21(1):729. PubMed ID: 34172021
[TBL] [Abstract][Full Text] [Related]
3. Vimentin and tumor-stroma ratio for neoadjuvant chemoradiotherapy response prediction in locally advanced rectal cancer.
Tian W; Yang Y; Qin Q; Zhang L; Wang Z; Su L; Zeng L; Chen H; Hu L; Hong J; Huang Y; Zhang Q; Zhao H
Cancer Sci; 2023 Feb; 114(2):619-629. PubMed ID: 36221784
[TBL] [Abstract][Full Text] [Related]
4. Prognostic prediction value of the clinical-radiomics tumour-stroma ratio in locally advanced rectal cancer.
Cai C; Hu T; Rong Z; Gong J; Tong T
Eur J Radiol; 2024 Jan; 170():111254. PubMed ID: 38091662
[TBL] [Abstract][Full Text] [Related]
5. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
6. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].
Shu Z; Fang S; Ding Z; Mao D; Pang P; Gong X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1051-1058. PubMed ID: 30269327
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of carcinoembryonic antigen combined with carbohydrate antigen 19-9 following neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Zheng Z; Wang X; Lu X; Huang Y; Chi P
Colorectal Dis; 2021 Sep; 23(9):2320-2330. PubMed ID: 33900006
[TBL] [Abstract][Full Text] [Related]
9. The Value of Endoscopy as a Predictive Factor when Evaluating the Clinical Response to Neoadjuvant Chemoradiotherapy for Patients with Rectal Cancer.
Bengulescu I; Radu P; Iorga C; Bratucu M; Pasnicu C; Garofil D; Popa F; Strambu V
Chirurgia (Bucur); 2020; 115(3):373-379. PubMed ID: 32614293
[No Abstract] [Full Text] [Related]
10. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
[No Abstract] [Full Text] [Related]
11. [Expression of CD133 in rectal cancer tissues and its relationship with neoadjuvant chemoradiotherapy].
Li D; Wu H; Feng R; Zhong D; Luo Y; Xiao Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jun; 19(6):690-4. PubMed ID: 27353106
[TBL] [Abstract][Full Text] [Related]
12. Clinical predictors of rectal cancer response after neo-adjuvant (Chemo)Radiotherapy in Australia and New Zealand: Analysis of the Bi-National Colorectal Cancer Audit (BCCA).
Liu J; Lee JYT; Bedrikovetski S; Traeger L; Moore JW; Perry JL; Kroon HM; Sammour T
Eur J Surg Oncol; 2023 Nov; 49(11):107070. PubMed ID: 37717474
[TBL] [Abstract][Full Text] [Related]
13. Clinical predictors of response to chemoradiotherapy for rectal cancer as an aid to organ preservation.
Fischer J; Eglinton TW; Frizelle FA
ANZ J Surg; 2021 Jun; 91(6):1190-1195. PubMed ID: 33404195
[TBL] [Abstract][Full Text] [Related]
14. The prognostic role of TCF4 expression in locally advanced rectal cancer patients treated with neoadjuvant chemoradiotherapy.
Dou X; Wang R; Meng X; Yan H; Jiang S; Zhu K; Xu X; Chen D; Song X; Mu D
Cancer Biomark; 2015; 15(2):181-8. PubMed ID: 25519018
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in patients with complete response of the tumour (ypT0) after neoadjuvant chemoradiotherapy and radical resection of rectal cancer.
Zhang H; Sun G; Zheng K; Lou Z; Gao XH; Meng RG; Furnée EJB; Zhang W
ANZ J Surg; 2021 Apr; 91(4):E190-E195. PubMed ID: 33559307
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients.
Lopes-Ramos CM; Habr-Gama A; Quevedo Bde S; Felício NM; Bettoni F; Koyama FC; Asprino PF; Galante PA; Gama-Rodrigues J; Camargo AA; Perez RO; Parmigiani RB
BMC Med Genomics; 2014 Dec; 7():68. PubMed ID: 25496125
[TBL] [Abstract][Full Text] [Related]
17. MRI T2-weighted sequences-based texture analysis (TA) as a predictor of response to neoadjuvant chemo-radiotherapy (nCRT) in patients with locally advanced rectal cancer (LARC).
Crimì F; Capelli G; Spolverato G; Bao QR; Florio A; Milite Rossi S; Cecchin D; Albertoni L; Campi C; Pucciarelli S; Stramare R
Radiol Med; 2020 Dec; 125(12):1216-1224. PubMed ID: 32410063
[TBL] [Abstract][Full Text] [Related]
18. [Advances in the prediction of the efficacy and sensitivity of neoadjuvant chemoradiotherapy in rectal cancer].
Ji Q; Li YF; Wu T
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):392-397. PubMed ID: 31054555
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of changes in the level of carbohydrate antigen 19-9 in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Zheng Z; Wang X; Huang Y; Lu X; Chi P
Colorectal Dis; 2020 Dec; 22(12):2068-2077. PubMed ID: 32936987
[TBL] [Abstract][Full Text] [Related]
20. The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation.
Carpinetti P; Donnard E; Bettoni F; Asprino P; Koyama F; Rozanski A; Sabbaga J; Habr-Gama A; Parmigiani RB; Galante PA; Perez RO; Camargo AA
Oncotarget; 2015 Nov; 6(35):38360-71. PubMed ID: 26451609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]